Isracann To Acquire Natural Health Medicine Developer Praesidio Health For $3.14M
Isracann Biosciences Inc. (CSE:IPOT) (XFRA:A2PT0E) (OTC: ISCNF) has entered into a binding letter of intent to acquire Praesidio Health Inc. of Canada, a medical research company.
